Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.51    -0.19 (-7.04%)
Bid:
2.50
Ask:
2.69
Spread: 0.19 (7.60%)
Market Cap: £2.59m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Transaction in Own Shares

18 Jul 2024 07:00

RNS Number : 8444W
Litigation Capital Management Ltd
18 July 2024
 

18 July 2024

Litigation Capital Management Limited

("LIT", the "Company" or the "Group")

Transaction in Own Shares

 

The Company announces that Canaccord Genuity Limited ("Canaccord") has made the following purchases of ordinary shares of no par value in the capital of the Company ("Ordinary Shares"), on its behalf on the London Stock Exchange, pursuant to the Share Buyback Programme announced on 5 October 2023.

Date of purchase

17 July 2024

Number of Ordinary Shares purchased (aggregated volume):

22,000

Highest Price paid per Ordinary Share (p):

112.50

Lowest Price paid per Ordinary Share (p):

112.00

Volume Weighted Average Price paid per Ordinary Share (p):

112.27

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Canaccord holds the repurchased shares on behalf of the Company. Following the purchase, the number of Ordinary Shares in issue and admitted to trading on AIM will be 116,327,003 excluding shares held by Canaccord (being the "Total Share Capital"). Canaccord on behalf of the Company will hold 2,873,329 ordinary shares, representing approximately 2.47% per cent of the Total Share Capital.

 

This figure of 116,327,003 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Company and Canaccord will make further announcements in due course following the completion of any further purchases pursuant to the Share Buyback Programme.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord on behalf of the Company.

Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

3,015

112.50

11:51:25

London Stock Exchange

3,015

112.50

11:51:27

London Stock Exchange

3,015

112.50

12:18:08

London Stock Exchange

2,955

112.50

12:18:10

London Stock Exchange

10,000

112.00

08:56:19

London Stock Exchange

 

Enquiries

 

Litigation Capital Management

c/o Tavistock

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam / Alex Orr

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

Tavistock (PR and IR)

Tel: 020 7920 3150

Tim Pearson

Katie Hopkins

lcm@tavistock.co.uk

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its income from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDLLFZDLEBBZ
Date   Source Headline
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSExercise of Awards
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSExercise of Awards
18th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:01 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 202411:32 amRNSResult of AGM
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 202411:55 amRNSPositive update on Fund I investment
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:01 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSDividend currency entitlement
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20246:05 pmRNSDividend Date
17th Sep 20245:20 pmRNSNotice of AGM
17th Sep 20247:01 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSFull year audited results for the YE 30 June 2024
13th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20242:25 pmRNSResignation of Director
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:01 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.